Toshiaki Nishihata
Director/Board Member at RIBOMIC INC.
Toshiaki Nishihata active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RIBOMIC INC. | Director/Board Member | 31/05/2016 | - |
| Independent Dir/Board Member | 31/05/2016 | - | |
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Director/Board Member | 31/01/2018 | - |
Career history of Toshiaki Nishihata
Former positions of Toshiaki Nishihata
| Companies | Position | Start | End |
|---|---|---|---|
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | 31/07/1990 | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Director/Board Member | 31/03/2010 | - |
| President | 08/11/2010 | - | |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Director/Board Member | 08/11/2010 | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Director/Board Member | 13/01/2010 | - |
| Chief Tech/Sci/R&D Officer | 17/01/2010 | - | |
| Corporate Officer/Principal | 13/01/2010 | 08/11/2010 |
Statistics
International
| Japan | 4 |
| United States | 4 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| RIBOMIC INC. | Health Technology |
| Private companies | 4 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Santen Holdings U.S., Inc.
Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Finance |
| Upjohn Pharmaceuticals Ltd. | |
Trans Chromosomics, Inc.
Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Commercial Services |
- Stock Market
- Insiders
- Toshiaki Nishihata
- Experience
